Morphological differences in BMP-2-induced ectopic bone between solid and crushed hyaluronan hydrogel templates

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 5, 2013, Pages 1201-1209

  Hulsart Billström, Gry ^a   Piskounova, Sonya ^a   Gedda, Lars ^a   Andersson, Britt Marie ^a   Bergman, Kristoffer ^b   Hilborn, Jöns ^a   Larsson, Sune ^a   Bowden, Tim ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Termira AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN-2; CELL INFILTRATION; CHEMICAL CROSS-LINKING; ENZYMATIC ACTIVITIES; HYALURONAN HYDROGELS; MACROPOROUS STRUCTURES; RADIOACTIVE LABELING; THREE-DIMENSIONAL NETWORKS;

BONE; CROSSLINKING; FUNCTIONAL GROUPS; GELS; HYALURONIC ACID; POLYVINYL ALCOHOLS;

HYDROGELS;

BONE MORPHOGENETIC PROTEIN 2; HYALURONIC ACID; HYDROXYAPATITE; IODINE 125; POLYVINYL ALCOHOL; DRUG IMPLANT; HYDROGEL;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MATRIX; BONE MINERAL; BONE RADIOGRAPHY; BONE TISSUE; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; CROSS LINKING; CRUSHED HYDROGEL; DRUG RELEASE; ENZYME ACTIVITY; EX VIVO STUDY; EXPLANT; FUNCTIONAL MORPHOLOGY; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MATERIAL STATE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; POROSITY; PRIORITY JOURNAL; RAT; SOLID HYDROGEL; SURFACE PROPERTY; THREE DIMENSIONAL IMAGING; TRABECULAR BONE; ANIMAL; BONE DEVELOPMENT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHORISTOMA; DRUG EFFECT; DRUG IMPLANT; ORGAN SIZE; PATHOLOGY; SKIN DISEASE; SPRAGUE DAWLEY RAT; CHEMICALLY INDUCED; DRUG EFFECTS; PHARMACOKINETICS; PHARMACOLOGY;

RATTUS;

ANIMALS; BONE DENSITY; BONE MORPHOGENETIC PROTEIN 2; CHORISTOMA; DRUG IMPLANTS; HYALURONIC ACID; HYDROGEL; MALE; ORGAN SIZE; OSTEOGENESIS; POROSITY; RATS; RATS, SPRAGUE-DAWLEY; SKIN DISEASES; SURFACE PROPERTIES;

EID: 84891648000     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-4877-6     Document Type: Article

References (45)

1. Athanasiou KA, Zhu C, Lanctot DR, Agrawal CM, Wang X. Fundamentals of biomechanics in tissue engineering of bone. Tissue Eng. 2000;6:361-81.
2. Urist M. R. Bone: formation by autoinduction. Science. 1965; 150:893-9.
3. Wozney JM. Overview of bone morphogenetic proteins. Spine. 2002;27:52-8.
4. Marsell R, Einhorn TA. The role of endogenous bone morphogenetic proteins in normal skeletal repair. Injury. 2009;40(Suppl 3):54-7.
5. Marsell R, Einhorn TA. Emerging bone healing therapies. J Orthop Trauma. 2010;24(Suppl 1):54-8.
6. Poynton AR, Lane JM. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine (Phila Pa 1976). 2002;27:40-8.
7. Li RH, Wozney JM. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol. 2001;19:255-65.
8. Saito N, Takaoka K. New synthetic biodegradable polymers as BMP carriers for bone tissue engineering. Biomaterials. 2003;24: 2287-93.
9. Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev. 2003;55:1613-29.
10. McKay WF, Peckham SM, Badura JM. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE bone graft). Int Orthop. 2007;31:729-34.
11. Uludag H, Friess W, Williams D, Porter T, Timony G, D'Augusta D, Blake C, Palmer R, Biron B, Wozney J. rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics. Ann NY Acad Sci. 1999;875:369-78.
12. Zara JN, Siu RK, Zhang X, Shen J, Ngo R, Lee M, Li W, Chiang M, Chung J, Kwak J, Wu BM, Ting K, Soo C. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A. 2011;17:1389-99.
13. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011;11:471-91.
14. Keefe J, Wauk L, Chu S, DeLustro F. Clinical use of injectable bovine collagen: A decade of experience. Clin Mater. 1992;9:155-62.
15. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: The road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med. 2008;2:81-96.
16. Knudson CB, Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol. 2001;12:69-78.
17. Delguerra RS, Cascone MG, Barbani N, Lazzeri L. Biological characterization of hydrogels of poly(vinyl alcohol) and hyaluronic- Acid. J Mater Sci Mater Med. 1994;5:613-6.
18. Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc Chem Res. 2000;33:94-101.
19. Jia X, Colombo G, Padera R, Langer R, Kohane DS. Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid. Biomaterials. 2004;25:4797-804.
20. Kurisawa M, Chung J, Yang Y, Gao S, Uyama H. Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine conjugates for drug delivery and tissue engineering. Chem Commun (Camb). 2005;34:4312-4.
21. Jia X, Yeo Y, Clifton RJ, Jiao T, Kohane DS, Kobler JB, Zeitels SM, Langer R. Hyaluronic acid-based microgels and microgel networks for vocal fold regeneration. Biomacromolecules. 2006; 7:3336-44.
22. Duflo S, Thibeault SL, Li W, Shu XZ, Prestwich GD. Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng. 2006;12:2171-80.
23. Liu Y, Shu XZ, Prestwich GD. Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng. 2006;12:3405-16.
24. Darr A, Calabro A. Synthesis and characterization of tyramine-based hyaluronan hydrogels. J Mater Sci Mater Med. 2009;20:33-44.
25. Xu X, Jha AK, Harrington DA, Farach-Carson MC, Jia X. Hyaluronic acid-based hydrogels: from a natural polysaccharide to complex networks. Soft Matter. 2012;8:3280-94.
26. Bergman K, Engstrand T, Hilborn J, Ossipov D, Piskounova S, Bowden T. Injectable cell-free template for bone-tissue formation. J Biomed Mater Res Part A. 2009;91:1111-8.
27. Piskounova S, Rojas R, Bergman K, Hilborn J. The effect of mixing on the mechanical properties of hyaluronan-based injectable hydrogels. Macromol Mater Eng. 2011;296:944-51.
28. Docherty-Skogh AC, Bergman K, Waern MJ, Ekman S, Hultenby K, Ossipov D, Hilborn J, Bowden T, Engstrand T. Bone morphogenetic protein-2 delivered by hyaluronan-based hydrogel induces massive bone formation and healing of cranial defects in minipigs. Plast Reconstr Surg. 2010;125:1383-92.
29. Hulsart-Billstrom G, Hu Q, Bergman K, Jonsson KB, Aberg J, Tang R, Larsson S, Hilborn J. Calcium phosphates compounds in conjunction with hydrogel as carrier for BMP-2: A study on ectopic bone formation in rats. Acta Biomater. 2011;7:3042-9.
30. Aulin C, Bergman K, Jensen-Waern M, Hedenqvist P, Hilborn J, Engstrand T. In situ cross-linkable hyaluronan hydrogel enhances chondrogenesis. J Tissue Eng Regen Med. 2011;5: 188-96.
31. Volodkin DV, Larionova NI, Sukhorukov GB. Protein encapsulation via porous CaCO3 microparticles templating. Biomacromolecules. 2004;5:1962-72.
32. Silva GA, Coutinho OP, Ducheyne P, Reis RL. Materials in particulate form for tissue engineering. 2. Applications in bone. J Tissue Eng Regen Med. 2007;1:97-109.
33. Carletti E, Motta A, Migliaresi C. Scaffolds for tissue engineering and 3D cell culture. Methods Mol Biol. 2011;695:17-39.
34. Leibold RA, Gilula LA. Sterilization of barium for vertebroplasty: An effective, reliable, and inexpensive method to sterilize powders for surgical procedures. Am J Roentgenol. 2002;179:198-200.
35. Hunter WM, Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962; 194:495-6.
36. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005;26:5474-91.
37. Salinas CN, Anseth KS. Mesenchymal stem cells for craniofacial tissue regeneration: designing hydrogel delivery vehicles. J Dent Res. 2009;88:681-92.
38. Skardal A, Zhang J, McCoard L, Oottamasathien S, Prestwich GD. Dynamically crosslinked gold nanoparticle-hyaluronan hydrogels. Adv Mater. 2010;22:4736-40.
39. Laurent TC, Fraser JR. Hyaluronan. FASEB J. 1992;6:2397-404.
40. Stern R. Hyaluronidases in cancer biology. Semin Cancer Biol. 2008;18:275-80.
41. Dadsetan M, Hefferan TE, Szatkowski JP, Mishra PK, Macura SI, LuL, Yaszemski MJ. Effect of hydrogel porosity onmarrowstromal cell phenotypic expression. Biomaterials. 2008;29:2193-202.
42. Betz MW, Yeatts AB, Richbourg WJ, Caccamese JF, Coletti DP, Falco EE, Fisher JP. Macroporous hydrogels upregulate osteogenic signal expression and promote bone regeneration. Biomacromolecules. 2010;11:1160-8.
43. Manes S, Mira E, Gomez-Mouton C, Lacalle RA, Martinez C. Cells on the move: A dialogue between polarization and motility. IUBMB Life. 2000;49:89-96.
44. Russell WMS, Burch RL. The principles of humane experimental technique. London: Methuen; 1959.
45. Goldberg AM, Zurlo J, Rudacille D. The three Rs and biomedical research. Science. 1996;272:1403.